| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 8e-07 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |